Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Leonard Da Silva
Affiliation
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
ORCID
Career Start Year
2007
Papers
34
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
33363813
Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.
Clin Case Rep
2020
33363813
Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.
Clin Case Rep
2020
29344954
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
J Pathol
2018
29344954
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
J Pathol
2018
27087319
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.
Am J Hum Genet
2016
27148852
The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Sci Rep
2016
27087319
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.
Am J Hum Genet
2016
26510554
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
J Pathol
2016
26510554
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
J Pathol
2016
27148852
The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Sci Rep
2016
25668816
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Oncotarget
2015
25668816
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Oncotarget
2015
26172396
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
J Pathol
2015
26172396
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
J Pathol
2015
24811120
Rad51 supports triple negative breast cancer metastasis.
Oncotarget
2014
24811120
Rad51 supports triple negative breast cancer metastasis.
Oncotarget
2014
22815804
Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.
PLoS One
2012
22807578
Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.
Mol Cancer Ther
2012
22718308
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Breast Cancer Res Treat
2012
22815804
Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.
PLoS One
2012
22718308
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Breast Cancer Res Treat
2012
22807578
Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.
Mol Cancer Ther
2012
21394826
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.
Hum Mutat
2011
22567347
Molecular aspects of breast cancer metastasis to the brain.
Genet Res Int
2011
21394826
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.
Hum Mutat
2011
21499728
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.
Endocr Pathol
2011
21787400
Rare variants in the ATM gene and risk of breast cancer.
Breast Cancer Res
2011
22567347
Molecular aspects of breast cancer metastasis to the brain.
Genet Res Int
2011
21787400
Rare variants in the ATM gene and risk of breast cancer.
Breast Cancer Res
2011
21499728
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.
Endocr Pathol
2011
20020529
Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance.
Hum Mutat
2010
20577821
The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.
Fam Cancer
2010
20436502
Pathology of hereditary breast cancer.
Mod Pathol
2010
20604919
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.
Breast Cancer Res
2010
20513136
Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.
Hum Mutat
2010
20206335
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Am J Hum Genet
2010
20593485
Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.
J Pathol
2010
19960244
Subtypes of familial breast tumours revealed by expression and copy number profiling.
Breast Cancer Res Treat
2010
20020529
Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significance.
Hum Mutat
2010
20642837
Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
Breast Cancer Res
2010
20513136
Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.
Hum Mutat
2010
20577821
The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.
Fam Cancer
2010
20604919
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.
Breast Cancer Res
2010
20593485
Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.
J Pathol
2010
20642837
Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
Breast Cancer Res
2010
20206335
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Am J Hum Genet
2010
20436502
Pathology of hereditary breast cancer.
Mod Pathol
2010
19960244
Subtypes of familial breast tumours revealed by expression and copy number profiling.
Breast Cancer Res Treat
2010
19031084
Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis.
Virchows Arch
2009
19047897
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Am J Surg Pathol
2009
1 - 50 of 68
Column Actions
Search
Recommended Authors
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year
2014
Number of shared co-authors
3
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Career Start Year
2009
Number of shared co-authors
9
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
6
Francisco Beca
Stanford University School of Medicine
Career Start Year
2008
Number of shared co-authors
2
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
6
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year
2007
Number of shared co-authors
7
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year
2006
Number of shared co-authors
4
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year
2005
Number of shared co-authors
5
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year
2004
Number of shared co-authors
11
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year
2002
Number of shared co-authors
11
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year
2002
Number of shared co-authors
6
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year
2002
Number of shared co-authors
2
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year
2001
Number of shared co-authors
0
Rita A Sakr
Universite Libre de Bruxelles
Career Start Year
2000
Number of shared co-authors
10
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
1
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year
1997
Number of shared co-authors
2
Susan J Done
University Health Network
Career Start Year
1994
Number of shared co-authors
1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
26
John M S Bartlett
University of Edinburgh
Career Start Year
1992
Number of shared co-authors
6
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year
1991
Number of shared co-authors
1
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1991
Number of shared co-authors
2
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year
1990
Number of shared co-authors
2
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year
1990
Number of shared co-authors
5
Paul J van Diest
University Medical Center Utrecht
Career Start Year
1989
Number of shared co-authors
5
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year
1989
Number of shared co-authors
19
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year
1988
Number of shared co-authors
5
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year
1986
Number of shared co-authors
0
Laura J Van't Veer
University of California San Francisco
Career Start Year
1984
Number of shared co-authors
22
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year
1981
Number of shared co-authors
14
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Sunil R Lakhani
University of Queensland
Co-authored papers
34
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers
21
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers
13
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers
9
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers
7
David E Goldgar
University of Utah
Co-authored papers
6
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers
6
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers
3
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers
3
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Co-authored papers
3
Fergus J Couch
Mayo Clinic
Co-authored papers
3
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers
3
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers
3
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Co-authored papers
2
David Clouston
Co-authored papers
2
Andrew J G Simpson
University of Hull
Co-authored papers
2
Parmjit S Jat
UCL Institute of Prion Diseases
Co-authored papers
2
Nicola Wayte
The Queensland Institute of Medical Research
Co-authored papers
2
Juliet D French
QIMR Berghofer Medical Research Institute
Co-authored papers
2
Sean M Grimmond
The University of Melbourne
Co-authored papers
2
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Co-authored papers
2
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
1
John S Mattick
Australia UNSW RNA Institute
Co-authored papers
1
Chris Jones
Co-authored papers
1
Jacqueline Armstrong
SA Pathology at the Women's and Children's Hospital
Co-authored papers
1
Stacey L Edwards
QIMR Berghofer Medical Research Institute
Co-authored papers
1
Peter J Oefner
Institute of Functional Genomics, University of Regensburg
Co-authored papers
1
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers
1
Alireza Heravi-Moussavi
Ferdowsi University of Mashhad
Co-authored papers
1
Pavel N Pichurin
Mayo Clinic
Co-authored papers
1
1 - 30